Early Career Investigators Grants
Three grants, in the amount of $30,000 each, are available for 2023-2024.
Applications are now closed for 2023.
Announcement of the grant recipients will be on June 22, 2023
Overview of the Early Career Investigators Grant Program
The Early Career Investigators Grant is a grant for gynecologic research, targeted to early-career clinician-investigators.
This grant is made possible through the generous grant sponsorship made by Pfizer.
The Early Career Investigators Grant is targeted to the field of gynecology, with a focus on medical management and pathophysiology of endometriosis, adenomyosis, fibroids, pelvic pain, and abnormal uterine bleeding.
The principal applicant must be a CanSAGE member in Canada who is an OB/GYN Resident, MIGS Fellow, or Gynecologist in the first 5 years of practice. Recipients must be early-career clinician-investigators, defined as 5 years following postgraduate training (allowing for leaves of absence).
The CanSAGE research selection committee will select the recipients of the grants.
Announcement of the grant recipients will be on June 22, 2023.
The recipients will then receive the grants on September 1, 2023.
Three grants of $30,000 each are available for 2023-2024. The funding must be used to complete research, and cannot be used for capital costs or educational program development.
Recipients have 2 years to complete the project. Upon completion of the research, recipients must provide a written report to the CanSAGE board and also present at the annual meeting.
About the Review Process & Criteria
• Applications will be reviewed by the CanSAGE grants committee and/or by invited external reviewers if the grant committee requires additional expertise.
• The grants committee will score the applications (recusing themselves from any applications which would represent a conflict of interest). The scores will be compiled, the applications discussed, and the most meritorious applications selected for funding on a conference call.
• Application review decisions are final.
The main focus of consideration will be;
• Scientific merit of the project
• Relevance of the proposal to the therapeutic area(s)
• Environment (and mentor, if applicable)
• Career trajectory